Michael F. Burgess - Head of Research & Development at SpringWorks Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head of Research & Development
Stock Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael F. Burgess since 9/17/2023

Holdings reported by Michael F. Burgess for SpringWorks Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49.6K $2.06M $41.53 Jul 18, 2022 Direct
Stock Option (Right to Buy) 48.9K Jan 6, 2022 Direct Common Stock

Transactions reported by Michael F. Burgess for SpringWorks Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.